The company is recalling the affected lot due to”mismatching of the embossing on the tablets with the embossing mentioned in the package insert in the distributed bottles.”
Macleods manufactured the affected lot in its Baddi-based manufacturing plant in Himachal Pradesh.
The company initiated the Class III recall in the US and Puerto Rico on January 5.
As per the USFDA, a Class III recall is initiated in a “situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.”
The US generic drug market was estimated to be around USD 115.2 billion in 2019. It is by far the largest market for pharmaceutical products in the world.
In the last financial year, India‘s pharma exports stood at around USD 24.62 billion with the US, the UK, South Africa, Russia, and Nigeria emerging as the top five destinations.
The Mumbai-based company has presence across various therapeutic segments including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment.
(With inputs from health)